{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:39:24Z","timestamp":1793417964243,"version":"4.5.0"},"reference-count":47,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","award":["PTDC\/MED535 ONC\/28660\/2017"],"award-info":[{"award-number":["PTDC\/MED535 ONC\/28660\/2017"]}],"id":[{"id":"https:\/\/ror.org\/00snfqn58","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Abbvie","award":["PTDC\/MED535 ONC\/28660\/2017"],"award-info":[{"award-number":["PTDC\/MED535 ONC\/28660\/2017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>This study aims at identifying molecular biomarkers differentiating responders and non-responders to treatment with Tumor Necrosis Factor inhibitors (TNFi) among patients with axial spondyloarthritis (axSpA). Whole blood mRNA and plasma proteins were measured in a cohort of biologic-na\u00efve axSpA patients (n = 35), pre and post (14 weeks) TNFi treatment with adalimumab. Differential expression analysis was used to identify the most enriched pathways and in predictive models to distinguish responses to TNFi. A treatment-associated signature suggests a reduction in inflammatory activity. We found transcripts and proteins robustly differentially expressed between baseline and week 14 in responders. C-reactive protein (CRP) and Haptoglobin (HP) proteins showed strong and early decrease in the plasma of axSpA patients, while a cluster of apolipoproteins (APOD, APOA2, APOA1) showed increased expression at week 14. Responders to TNFi treatment present higher levels of markers of innate immunity at baseline, and lower levels of adaptive immunity markers, particularly B-cells. A logistic regression model incorporating ASDAS-CRP, gender, and AFF3, the top differentially expressed gene at baseline, enabled an accurate prediction of response to adalimumab in our cohort (AUC = 0.97). In conclusion, innate and adaptive immune cell type composition at baseline may be a major contributor to response to adalimumab in axSpA patients. A model including clinical and gene expression variables should also be considered.<\/jats:p>","DOI":"10.3390\/biom14030382","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:34:46Z","timestamp":1710995686000},"page":"382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular Profiling of Axial Spondyloarthritis Patients Reveals an Association between Innate and Adaptive Cell Populations and Therapeutic Response to Tumor Necrosis Factor Inhibitors"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3955-0117","authenticated-orcid":false,"given":"Daniel","family":"Sobral","sequence":"first","affiliation":[{"name":"Applied Molecular Biosciences Unit, Life Sciences Department, Sciences and Technology School, NOVA University of Lisbon, 2829-516 Caparica, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-2629","authenticated-orcid":false,"given":"Ana Filipa","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Nova University of Lisbon, Av. Da Rep\u00fablica, 2780-157 Oeiras, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-5465","authenticated-orcid":false,"given":"Miguel","family":"Bernardes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of Porto, 4099-002 Porto, Portugal"},{"name":"Rheumatology Department, Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, 4200\u2013319 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Pinto","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar de Vila Nova de Gaia\/Espinho, 4434-502 Vila Nova de Gaia, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Santos","sequence":"additional","affiliation":[{"name":"NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal"},{"name":"Portuguese Institute of Rheumatology, 1050-034 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3529-1982","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Lagoas-Gomes","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar do T\u00e2mega e Sousa, Hospital Padre Am\u00e9rico, 4560-136 Penafiel, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Tavares-Costa","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Unidade Local de Sa\u00fade do Alto Minho, 4990-078 Ponte de Lima, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A. P.","family":"Silva","sequence":"additional","affiliation":[{"name":"I.CBR\u2014Institute for Clinical and Biomedical Research, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Rheumatology Department, Centro Hospitalar e Universit\u00e1rio de Coimbra, 3004-561 Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-8492","authenticated-orcid":false,"given":"Jo\u00e3o Madruga","family":"Dias","sequence":"additional","affiliation":[{"name":"NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal"},{"name":"Rheumatology Department, Centro Hospitalar M\u00e9dio Tejo, 2350-754 Torres Novas, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6224-9704","authenticated-orcid":false,"given":"Alexandra","family":"Bernardo","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, 4200\u2013319 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Gaillard","sequence":"additional","affiliation":[{"name":"D\u00e9partement M\u00e9dicaments et Technologies pour la Sant\u00e9 (DMTS), Universit\u00e9 Paris-Saclay, CEA, INRAE, SPI, F-30200 Bagnols-sur-C\u00e8ze, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1589-445X","authenticated-orcid":false,"given":"Jean","family":"Armengaud","sequence":"additional","affiliation":[{"name":"D\u00e9partement M\u00e9dicaments et Technologies pour la Sant\u00e9 (DMTS), Universit\u00e9 Paris-Saclay, CEA, INRAE, SPI, F-30200 Bagnols-sur-C\u00e8ze, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Benes","sequence":"additional","affiliation":[{"name":"EMBL Genomics Core Facility, Meyerhofstr. 1, D-69117 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facia","family":"Domingues","sequence":"additional","affiliation":[{"name":"NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal"},{"name":"Escola Superior de Sa\u00fade, Instituto Polit\u00e9cnico de Set\u00fabal, 2910-761 Set\u00fabal, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Maia","sequence":"additional","affiliation":[{"name":"NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-4375","authenticated-orcid":false,"given":"Jaime C.","family":"Branco","sequence":"additional","affiliation":[{"name":"NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal"},{"name":"Rheumatology Department, Centro Hospitalar de Lisboa Ocidental, Hospital Egas-Moniz, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-4203","authenticated-orcid":false,"given":"Ana Varela","family":"Coelho","sequence":"additional","affiliation":[{"name":"Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Nova University of Lisbon, Av. Da Rep\u00fablica, 2780-157 Oeiras, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando M.","family":"Pimentel-Santos","sequence":"additional","affiliation":[{"name":"NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal"},{"name":"Rheumatology Department, Centro Hospitalar de Lisboa Ocidental, Hospital Egas-Moniz, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/BOR.0b013e32833ac5cc","article-title":"New approaches to diagnosis and classification of axial and peripheral spondyloarthritis","volume":"22","author":"Rudwaleit","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10067-011-1854-7","article-title":"Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts","volume":"31","author":"Ribeiro","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"Ramiro","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/annrheumdis-2014-205322","article-title":"Efficacy of TNF\u03b1 blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: A meta-analysis","volume":"74","author":"Callhoff","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e001005","DOI":"10.1136\/rmdopen-2019-001005","article-title":"Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study","volume":"5","author":"Baraliakos","year":"2019","journal-title":"RMD Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/01.bor.0000163194.48723.64","article-title":"Management and treatment of ankylosing spondylitis","volume":"17","author":"Zochling","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00393-019-00707-z","article-title":"Aktuelle Therapie der axialen Spondyloarthritis: Klinische Wirksamkeit","volume":"79","author":"Kiltz","year":"2020","journal-title":"Z. F\u00fcr Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6983272","DOI":"10.1155\/2020\/6983272","article-title":"Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis","volume":"2020","author":"Gentileschi","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/acr.23465","article-title":"Profiling Response to Tumor Necrosis Factor Inhibitor Treatment in Axial Spondyloarthritis","volume":"70","author":"Alazmi","year":"2018","journal-title":"Arthritis Care Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2013.10.009","article-title":"Whole-blood gene expression profiling in ankylosing spondylitis identifies novel candidate genes that may contribute to the inflammatory and tissue-destructive disease aspects","volume":"286","author":"Chen","year":"2013","journal-title":"Cell. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40265-019-01075-3","article-title":"Secukinumab: A Review in Ankylosing Spondylitis","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102398","DOI":"10.1016\/j.jaut.2019.102398","article-title":"Treat to target in axial spondyloarthritis: From its concept to its implementation","volume":"110","author":"Dougados","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","article-title":"Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis","volume":"43","author":"Nell","year":"2004","journal-title":"Rheumatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/ar4561","article-title":"The window of opportunity: A relevant concept for axial spondyloarthritis","volume":"16","author":"Robinson","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/ard.2007.073098","article-title":"MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis","volume":"67","author":"Rudwaleit","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.2003.016386","article-title":"Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor blockers in ankylosing spondylitis","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2009.06.149","article-title":"Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells","volume":"387","author":"Tanino","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/clpt.2009.244","article-title":"CD11c as a Transcriptional Biomarker to Predict Response to Anti-TNF Monotherapy With Adalimumab in Patients with Rheumatoid Arthritis","volume":"87","author":"Hernandez","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Thomson, T.M., Lescarbeau, R.M., Drubin, D.A., Laifenfeld, D., de Graaf, D., Fryburg, D.A., Littman, B., Deehan, R., and Van Hooser, A. (2015). Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis. BMC Med. Genom., 8.","DOI":"10.1186\/s12920-015-0100-6"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.38947","article-title":"Modular Analysis of Peripheral Blood Gene Expression in Rheumatoid Arthritis Captures Reproducible Gene Expression Changes in Tumor Necrosis Factor Responders","volume":"67","author":"Oswald","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-019-1999-3","article-title":"Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor","volume":"21","author":"Farutin","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","first-page":"209","article-title":"Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis\u20142016 update","volume":"42","author":"Machado","year":"2017","journal-title":"Acta Reumatol. Port."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","article-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis","volume":"44","author":"Anderson","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","article-title":"Development and preselection of criteria for short term improvement after anti-TNF treatment in ankylosing spondylitis","volume":"63","author":"Brandt","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2008.102277","article-title":"From gene expression to serum proteins: Biomarker discovery in ankylosing spondylitis","volume":"69","author":"Haroon","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/gene.2017.19","article-title":"Transcriptome analysis of ankylosing spondylitis patients before and after TNF-\u03b1 inhibitor therapy reveals the pathways affected","volume":"18","author":"Wang","year":"2017","journal-title":"Genes Immun."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"(2010). The Australo-Anglo-American Spondyloarthritis Consortium (TASC) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet., 42, 123\u2013127.","DOI":"10.1038\/ng.513"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"re13","DOI":"10.1126\/stke.3572006re13","article-title":"Regulation and Function of IKK and IKK-Related Kinases","volume":"2006","author":"Hacker","year":"2006","journal-title":"Sci. STKE"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1194\/jlr.R051367","article-title":"Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: A review","volume":"55","author":"White","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.metabol.2016.05.007","article-title":"Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice","volume":"65","author":"Martineau","year":"2016","journal-title":"Metabolism"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1083\/jcb.127.6.1767","article-title":"A potential role for tetranectin in mineralization during osteogenesis","volume":"127","author":"Wewer","year":"1994","journal-title":"J. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/rheumatology\/kex448","article-title":"Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography","volume":"57","author":"Bruijnen","year":"2018","journal-title":"Rheumatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10067-019-04771-3","article-title":"Effects of 1-year anti-TNF-\u03b1 therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"Pusztai","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/rheumatology\/kez363","article-title":"The effect of tumour necrosis factor inhibitors on radiographic progression in axial spondyloarthritis: A systematic literature review","volume":"58","author":"Boers","year":"2019","journal-title":"Rheumatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2353\/jmoldx.2007.060175","article-title":"Isolation of Microarray-Grade Total RNA, MicroRNA, and DNA from a Single PAXgene Blood RNA Tube","volume":"9","author":"Voss","year":"2007","journal-title":"J. Mol. Diagn."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Robinson, M.D., and Oshlack, A. (2010). A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol., 11.","DOI":"10.1186\/gb-2010-11-3-r25"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor Infiltrating Immune Cells with CIBERSORT","volume":"Volume 1711","year":"2018","journal-title":"Cancer Systems Biology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Abbas, A.R., Wolslegel, K., Seshasayee, D., Modrusan, Z., and Clark, H.F. (2009). Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006098"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1093\/nar\/gkt660","article-title":"Quantitative set analysis for gene expression: A method to quantify gene set differential expression including gene-gene correlations","volume":"41","author":"Yaari","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-4939-1261-2_16","article-title":"Taking the Shortcut for High-Throughput Shotgun Proteomic Analysis of Bacteria","volume":"1197","author":"Hartmann","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/17435390.2016.1244299","article-title":"RNA-binding proteins are a major target of silica nanoparticles in cell extracts","volume":"10","author":"Klein","year":"2016","journal-title":"Nanotoxicology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/85686","article-title":"Large-scale analysis of the yeast proteome by multidimensional protein identification technology","volume":"19","author":"Washburn","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1021\/ac0498563","article-title":"A Model for Random Sampling and Estimation of Relative Protein Abundance in Shotgun Proteomics","volume":"76","author":"Liu","year":"2004","journal-title":"Anal. Chem."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/3\/382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:17:05Z","timestamp":1760105825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/3\/382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["biom14030382"],"URL":"https:\/\/doi.org\/10.3390\/biom14030382","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]}}}